Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients

Chinese Journal of Oncology

Volumn 33, Issue 11, 2011, Pages 847-849

  Hang, Zhi Qiang ^a   Zheng, Min Feng ^a   Huang, Jie Hui ^a  

^a WUXI PEOPLE'S HOSPITAL   (China)

Author keywords

Carcinoembryonic antigen; Cytokeratin 19 fragments; Diagnosis; Lung neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT;

ACCURACY; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCHEMISTRY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; HUMANS; KERATIN-19; LUNG DISEASES, OBSTRUCTIVE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONIA; SMALL CELL LUNG CARCINOMA; TUBERCULOSIS, PULMONARY; TUMOR MARKERS, BIOLOGICAL;

EID: 83155173436     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.11.011     Document Type: Article

References (8)

1. Pujol JL, Grenier J, Dourès JP, et al. Serum fragment of cytokeratin subnit 19 measured by CyFRA21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res, 1993, 53:61-66. (Pubitemid 23019377)
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997, 111:1710-1717. (Pubitemid 27260107)
3. Mitauhashi N, T akahashi T, Sakruai H, et al. Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing carcinombryonic antigen (CEA) and CA19-9. Lung Cancer, 1995, 12:13-24.
4. The World Health Organization histological typing of lung tumors. Second edition. Am J Clin Pathol, 1982, 77:123-136.